DCE MRI is a well-accepted tool in the management of breast cancer, but continues to face technical challenges and concerns regarding gadolinium deposition. In this work, we proposed a novel Multitasking DCE technique, which enables adequate breast coverage, 0.9-mm isotropic spatial resolution, 1.5-s temporal resolution, dynamic T1 mapping throughout all DCE phases, and reduced dose of 0.02mmol/kg for the imaging of breast cancer. The in vivo studies demonstrated that the low-dose Multitasking DCE showed equivalent tumor delineation compared to standard DCE. The quantitative DCE parameters were repeatable in vivo and significantly different between normal breast and breast cancer.
This abstract and the presentation materials are available to members only; a login is required.